← Back to Search

Optical Imaging Technology

fNIRS Technology for Brain Activity Measurement

N/A

Waitlist Available

Led By Amir Gandjbakhche, Ph.D.

Research Sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18 years or greater

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up end of study

Awards & highlights

Study Summary

This trial is studying how well functional near-infrared imaging works in measuring brain activity. Researchers will compare results from this imaging to results from functional magnetic resonance imaging.

Who is the study for?

This trial is for healthy adults over 18 years old. It's not suitable for those with skin diseases, latex allergies, vascular diseases, or any condition that the lead researcher thinks would make participation unsafe. Participants must be able to consent to the study.Check my eligibility

What is being tested?

The study tests a non-invasive brain imaging technology called fNIR against standard fMRI results. Volunteers will wear a headband with light sources and detectors while performing tasks like reading or counting to measure brain activity.See study design

What are the potential side effects?

Since this trial involves non-invasive techniques and behavioral measures without drugs or invasive procedures, significant side effects are not expected. However, discomfort from wearing the headband may occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ end of study

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~end of study

This trial's timeline: 3 weeks for screening, Varies for treatment, and end of study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Collect functional optical imaging data

Validate NIRFI imaging data results with fMRI data

Secondary outcome measures

Assess any significant issues associated with NIRS optode placement

Assess neurovascular changes

Trial Design

1Treatment groups

Experimental Treatment

Group I: 1/All SubjectsExperimental Treatment3 Interventions

Imaging studies related to functional brain activation

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Institute on Deafness and Other Communication Disorders (NIDCD)NIH

328 Previous Clinical Trials

178,179 Total Patients Enrolled

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Lead Sponsor

1,963 Previous Clinical Trials

2,674,615 Total Patients Enrolled

1 Trials studying Cognition

180 Patients Enrolled for Cognition

United States Department of DefenseFED

861 Previous Clinical Trials

227,068 Total Patients Enrolled

Media Library

fNIRS Devices & Application (Optical Imaging Technology) Clinical Trial Eligibility Overview. Trial Name: NCT01212029 — N/A

Cognition Research Study Groups: 1/All Subjects

Cognition Clinical Trial 2023: fNIRS Devices & Application Highlights & Side Effects. Trial Name: NCT01212029 — N/A

fNIRS Devices & Application (Optical Imaging Technology) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01212029 — N/A

Cognition Patient Testimony for trial: Trial Name: NCT01212029 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have signed up for this medical experimentation thus far?

"Affirmative, clinicaltrials.gov reveals that this trial is actively seeking participants since its posting on September 8th 2011 and the most recent update occurred on November 10th 2022. A total of 250 patients will be enrolled across 2 sites."

Answered by AI

Are enrollments for this medical trial still open?

"The details of this research, which were first listed on September 8th 2011 and last modified on November 10 2022, indicate that the trial is actively accepting new participants."

Answered by AI